Literature DB >> 12854389

The relationship between scoring systems and cytokine levels in neonatal sepsis.

H Caksen1, S Kurtoglu, I K Hallaç, H B Ustünbas, K Uzüm, H Kiliç.   

Abstract

In this study, 20 newborn infants with sepsis were evaluated and scored according to the criteria of Töllner and Rodwell and associates. Leukocyte count, serum C-reactive protein (CRP), tumour necrosis factor (TNF)-alpha and interluekin (IL)-6 levels were also studied in all infants. The aim of this study was to determine if a relationship exists between the scoring systems and the cytokine levels in neonatal sepsis. The infants were divided into two groups as blood culture positive and negative. Blood culture was positive in 12 (60%) infants. We did not find a significant difference for leukocyte count, cytokine levels and scoring systems between the blood culture positive and negative groups. However, we found a positive correlation between the scoring systems and serum CRP and TNF-alpha levels (P < 0.05), but no correlation with IL-6. In conclusion, we suggest that only serum CRP level without performing scoring and studying serum TNF-alpha concentration may be used in early diagnosis of neonatal sepsis. However, further studies are necessary to define this because of the small sample size of our pilot study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854389

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

1.  Utility of cytokine, adhesion molecule and acute phase proteins in early diagnosis of neonatal sepsis.

Authors:  M A Fattah; Al Fadhil A Omer; S Asaif; R Manlulu; T Karar; A Ahmed; A Aljada; Ayman M Saleh; Shoeb Qureshi; A Nasr
Journal:  J Nat Sci Biol Med       Date:  2017 Jan-Jun

2.  Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis.

Authors:  Birsen Ucar; Bilal Yildiz; M Arif Aksit; Coskun Yarar; Omer Colak; Yildiz Akbay; Ertugrul Colak
Journal:  Mediators Inflamm       Date:  2008-11-16       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.